3/4/2015 - 3:43 PM EST - Sirona Biochem Corp. : announced that Wanbang Biopharmaceuticals has successfully completed the toxicology study in the pre-clinical validation of its anti-diabetic SGLT2 Inhibitor, SBM-TFC-039, for the treatment of Type 2 diabetes.In the study, SBM-TFC-039 was orally administered to Sprague Dawley (SD) rats for 14 days to evaluate safety and simultaneously observe toxicokinetics. Dosing of SBM-TFC-039 was either 0, 100, 300 or 800 milligrams per kilogram per day (mg/kg/day) as well as 300 mg/kg/day of the reference drug Canagliflozin. Sirona Biochem Corp.
shares V.SBM are trading up $0.01 at $0.18.
3/4/2015 - 3:41 PM EST - ACT360 Solutions Ltd. : has signed a licensing agreement with iLeads.com LLC of Newport Beach, California to operate and monetize its consumer website www.neighborhoodiq.com. The partnership's objective is to find, qualify, and deliver highly engaged customers for providers of goods and services to U.S. homeowners. ACT360 Solutions Ltd.
shares V.AKM are trading unchanged at $0.09.
3/4/2015 - 11:45 AM EST - Eguana Technologies Inc : has exercised its previously-announced right to acquire all 314 limited partnership units in EGT Markets Limited Partnership issued on December 31, 2014 in exchange for 951,420 common shares of Eguana. The common shares issued in exchange for the Units are subject to resale restrictions which expire on May 1, 2015. Eguana Technologies Inc
shares V.EGT are trading unchanged at $0.43.
3/4/2015 - 11:43 AM EST - Resverlogix Corp. : announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE. The objective of this collaborative program was to develop quantitative models and identify variables that contribute to drug response, and the incidence of major adverse cardiac events. Resverlogix Corp.
shares T.RVX are trading up $0.03 at $0.93.
3/4/2015 - 11:42 AM EST - Smartcool Systems Inc. : announced that in partnership with EkoStar, a leading integrator of energy efficiency solutions for its clients, that they have installed ECO in 16 data centres owned and operated by Orange Polska. Orange Polska is Poland's leading telecom provider with over 23 million customers and owns the largest technical infrastructure in Poland supporting its key operations. Smartcool Systems Inc.
shares V.SSC are trading unchanged at $0.06.
3/4/2015 - 9:51 AM EST - Mosaic Capital Corporation : confirmed the closing today of an additional placement of units of Mosaic. The private placement consisted of the issuance by Mosaic of 5,200 units at a price of $1,000 per Unit for aggregate gross proceeds of $5.2 million. Each Unit is comprised of one private yield security of Mosaic and one private yield security purchase warrant. Mosaic Capital Corporation
shares V.M are trading up $0.18 at $11.73.
3/4/2015 - 9:49 AM EST - SENSIO Technologies Inc. : announced today that it has developed a new version of its award-winning SENSIO® Hi-Fi 3D format which is compatible with the side-by-side decoders found in the vast majority of 3D devices available on the market. SENSIO Technologies Inc.
shares V.SIO are trading unchanged at $0.16.
3/4/2015 - 9:48 AM EST - InterRent Real Estate Investment Trust : reported financial results for the fourth quarter and year ended December 31, 2014. Gross rental revenue increased by $5.7 million, or 9.5%, over 2013 while operating revenue increased by $4.9 million, or 8.1%. Net Operating Income (NOI) increased by $0.9 million, or 9.7%, for the quarter compared to Q4 2013 and by $1.8 million, or 5.1%, for the year compared to 2013. InterRent Real Estate Investment Trust
shares T.IIP.UN are trading up $0.01 at $6.43.
3/4/2015 - 9:46 AM EST - Ventripoint Diagnostics Ltd. : provided a corporate update and announced its intention to issue up to $200,000 of 12% unsecured convertible debentures. Ventripoint Diagnostics Ltd.
shares V.VPT are trading unchanged at $0.01.
